Please join Foley and Charles River Associates for a round table discussion with Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee, and fellow panelists, to discuss:
- Myths about the Chinese health care system
- Competition and collaboration with local companies
- Opening China’s hospital market
- Price and market access issues faced by multinational pharmaceutical companies in China
Introduction
- Adria Warren, Senior Counsel, Foley & Lardner LLP
Moderator
- Dr. Elizabeth Xiao-Ru Wang, Principal, Charles River Associates
Panelists
- Dr. Jim Ewing, Partner, Foley & Lardner LLP
- Dr. Zack Fang, member of the Chinese State Counsel Health Care Reform Expert Advisory Committee
- Xiaolin Zhou, Partner, Jun He Law Offices
There is no cost to participate in this program; however, pre-registration is required. For additional information, please contact Delia Dai at [email protected].
People
Related Insights
December 11, 2025
Foley Viewpoints
Antitrust Risks and Compliance Strategies in Intellectual Property Portfolio Management
This article analyzes how intellectual property portfolio management can simultaneously promote innovation and present potential…
December 11, 2025
Foley Viewpoints
CARB Releases Proposed Regulations for SB 261 and 253
On December 9, 2025, the California Air Resources Board (CARB) released its proposed regulatory text for the initial regulations…
December 11, 2025
Innovative Technology Insights
OCC Issues Another Crypto-Friendly Interpretive Letter: Permissibility of Riskless Principal Crypto-Assets Transactions
On December 9, 2025, the Office of the Comptroller of the Currency (OCC) issued Interpretive Letter 1188 (IL 1188), confirming that a national bank is permitted, as part of the business of banking, to engage in riskless principal crypto-assets transactions.